Novo Nordisk A/S (ADR) (NVO): Novo Nordisk A/S – Shareholder/Analyst Call

Novo Nordisk A/S (ADR) (NVO): Novo Nordisk A/S – Shareholder/Analyst Call

Filed under: drug abuse treatment outcome study

That is going to take like 30 minutes or so, and then we have time for discussion, and you can ask questions about any of the other studies we have as — once we have shown these forward-looking statements. We have quite a lot of presentations, a total …
Read more on Seeking Alpha

Zonisamide OK for New Partial Seizures

Filed under: drug abuse treatment outcome study

Baulac noted that a number of past trials have compared the two drugs head-to-head and shown non-inferiority for zonisamide as a monotherapy, although none of these studies reported long-term outcomes for treatment of newly diagnosed partial epilepsy …
Read more on MedPage Today

Addiction: Can you ever really completely leave it behind?

Filed under: drug abuse treatment outcome study

Scientists are currently trying to answer some of the 'chicken and egg' questions surrounding the abuse of drugs. In particular, one of those questions is whether individuals who abuse psychostimulants like cocaine are more impulsive and show …
Read more on EurekAlert (press release)